0000950170-23-026422.txt : 20230605
0000950170-23-026422.hdr.sgml : 20230605
20230605170324
ACCESSION NUMBER: 0000950170-23-026422
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230601
FILED AS OF DATE: 20230605
DATE AS OF CHANGE: 20230605
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Atkinson Edward Morrow III
CENTRAL INDEX KEY: 0001914164
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39122
FILM NUMBER: 23993592
MAIL ADDRESS:
STREET 1: C/O 89BIO, INC.
STREET 2: 142 SANSOME STREET, SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 89bio, Inc.
CENTRAL INDEX KEY: 0001785173
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831114349
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: (415) 432-9270
MAIL ADDRESS:
STREET 1: 142 SANSOME STREET
STREET 2: SECOND FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
4
1
ownership.xml
4
X0407
4
2023-06-01
0001785173
89bio, Inc.
ETNB
0001914164
Atkinson Edward Morrow III
C/O 89BIO, INC.
142 SANSOME STREET, 2ND FLOOR
SAN FRANCISCO
CA
94104
true
false
false
false
false
Common Stock
2023-06-01
4
M
false
6250
2.61
A
6250
D
Common Stock
2023-06-01
4
S
false
6250
17.91
D
0
D
Stock Option (Right to Buy)
2.61
2023-06-01
4
M
false
6250
0.00
D
2032-05-25
Common Stock
6250
0.00
D
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on January 30, 2023 in multiple trades at prices ranging from $17.53 to $18.18. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
This option represents a right to purchase a total of 6,250 shares of the Issuer's Common Stock, which vested in full on May 16, 2023.
/s/ Ryan A. Murr, as attorney-in-fact for Edward Morrow Atkinson III
2023-06-05